AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,900.00p
   
  • Change Today:
      66.00p
  • 52 Week High: 12,940.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.71m
  • Volume: 3,180,951
  • Market Cap: £200,042m
  • RiskGrade: 123
  • Beta: 1.32

Regulatory News

9M and Q3 2025 results 06-Nov-2025 07:00 RNS
Result of General Meeting 03-Nov-2025 16:00 RNS
Total Voting Rights 03-Nov-2025 15:00 RNS
Director Declaration 28-Oct-2025 07:05 RNS
Koselugo (selumetinib) approved in the EU 28-Oct-2025 07:00 RNS
Tezspire Approved in EU for CRSwNP 22-Oct-2025 07:00 RNS
US FDA Approves Tezspire in CRSwNP 20-Oct-2025 07:05 RNS
Positive CHMP opinion for subcutaneous Saphnelo 20-Oct-2025 07:00 RNS
Agreement with US Govt to lower medicine prices 13-Oct-2025 07:00 RNS
Baxdrostat met primary endpoint in Bax24 Ph3 trial 07-Oct-2025 07:00 RNS
Datroway improved OS and PFS in TROPION-Breast02 06-Oct-2025 07:30 RNS
Total Voting Rights 01-Oct-2025 15:00 RNS
Enhertu improved IDFS in early BC in DB-05 29-Sep-2025 07:30 RNS
AZN harmonises listing structure 29-Sep-2025 07:00 RNS
Director/PDMR Shareholding 25-Sep-2025 16:30 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,900.00p
Change Today 66.00p
% Change 0.51 %
52 Week High 12,940.00p
52 Week Low 9,667.00p
Volume 3,180,951
Shares Issued 1,550.71m
Market Cap £200,042m
Beta 1.32
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 07-Nov-2025

Time Volume / Share Price
14:53 0 @ 12,874.00p
14:47 0 @ 12,864.00p
14:47 0 @ 12,864.00p
14:47 0 @ 12,864.00p
14:47 0 @ 12,864.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page